Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
About
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.
The Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) is a federally-funded research program designed to support Centers that integrate clinical and translational research focused on atopic dermatitis. This grant opportunity is ideal for research institutions, medical centers, and academic organizations conducting cutting-edge work in dermatology and immunology. The program emphasizes improving our understanding and management of atopic dermatitis, with particular focus on chronic skin inflammation and the defense mechanisms of the skin. Eligible applicants should have the infrastructure, expertise, and multidisciplinary teams necessary to conduct both clinical and translational research at the highest levels. The ADRN program represents a significant opportunity for institutions seeking to advance the field of atopic dermatitis research, improve patient outcomes, and establish themselves as leaders in dermatological science. Researchers and institutions working on innovative approaches to understanding skin barrier function, immune responses, and therapeutic interventions for atopic dermatitis should strongly consider applying. This program supports collaborative, center-based research that can generate meaningful breakthroughs in treating this prevalent and debilitating skin condition.
Funding Facts
● Applications openDeadline
September 24, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by funding cycle
Deadline
2026-09-24
Grant Type
federal
Application Cycle
Annual cycle (Deadline: September 24, 2026)
Best For
Research institutions, academic medical centers, and universities conducting clinical and translational dermatology research
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Frequently Asked Questions
Who is eligible for Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)?
Domestic U.S. organizations and institutions are eligible to apply. However, foreign organizations and non-domestic components of U.S. organizations are not eligible. Foreign components as defined in the NIH Grants Policy Statement are also not allowed. For complete eligibility information, including specific organizational requirements and qualifications, refer to Section III of the Notice of Funding Opportunity (NOFO) on the official NIH website.
How much funding does Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) provide?
The specific funding amounts for this program cycle are not currently listed. Funding levels may vary by funding cycle and the scope of proposed research. Applicants should consult the official NOFO and NIH website for current budget information and allowable funding amounts for their proposed Center.
How do I apply for Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)?
Applications for the ADRN program are submitted through the NIH grants submission system. Prospective applicants should review the complete Notice of Funding Opportunity (NOFO) for detailed application instructions, required documents, submission procedures, and specific program requirements. Visit the NIH website directly to access the NOFO, download application materials, and submit your application before the deadline of September 24, 2026.
What can Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) funding be used for?
ADRN funding supports Centers that integrate clinical and translational research to improve understanding and management of atopic dermatitis. Research emphasis areas include chronic skin inflammation and skin defense mechanisms. The program supports both clinical trials (optional) and translational research components. Funding may cover personnel, equipment, and research activities aligned with advancing atopic dermatitis science and patient outcomes.
Last updated: July 5, 2026